the aid library

Filter

611

ACT-A - Urgent Priorities & Financing Requirements at 10 November 2020

World Health Organization (WHO), The Global Fund, Gavi et al. World Health Organization (WHO) (2020) CC

Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o ... more

Ending disease in Africa: vision, strategies and special initiatives, 2023-2030

World Health Organisation (WHO) (2023) C_WHO

While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa ... more

Lao People’s Democratic Republic-WHO Country Cooperation Strategy 2024–2028

World Health Organization WHO (2023) C_WHO

This country cooperation strategy (CCS) outlines how the World Health Organization (WHO) will work with the Lao People’s Democratic Republic over the next five years (2024–2028), supporting the implementation of the five-year health sector development plans and the Health Sector Reform Strategy ... 2021–2030 to attain the Sustainable Development Goals (SDGs) by 2030. The Lao People’s Democratic Republic experienced substantial economic growth in the 30 years prior to the coronavirus disease (COVID-19) pandemic, contributing to reduced poverty and significant progress toward the SDGs. However, the COVID-19 pandemic brought this development to a halt. It was anticipated that the COVID-19 recovery and the tremendous population growth in recent years would provide opportunities for a shift toward more sustainable and inclusive development in the years ahead. In 2023, however, the contrary was the case. Rural residents, including many ethnic minorities, continued to face marginalization because of limited access to education, health care and economic opportunities. Despite the challenges of COVID-19 and other disease outbreaks, the country has made significant improvements in health. Nonetheless, progress has been uneven and not everyone has benefited from these achievements. In the mountainous region, many people lack access to quality health care because of the unequal distribution of well-trained health-care workers. Preventable deaths due to poor-quality health care for children and newborns, infants and mothers remain a concern, as do communicable diseases such as sexually transmitted infections and tuberculosis. The increasing burden of noncommunicable diseases and the health impact of worsening climate change further heighten the need for strengthened and resilient health systems, which are at risk due to an underfunded health sector and weak economy. This CCS aims to address remaining and future challenges as well as health needs while creating an impact that is sustainable. It identifies three strategic priorities and nine deliverables (Table 1) to support the attainment of the national vision of Health for all by all, as articulated in the 9th Health Sector Development Plan 2021–2025. It contributes to the country’s goals to achieve universal health coverage, graduate from least developed country status by 2026 and attain SDGs by 2030. more

Guidance on mainstreaming biodiversity for nutrition and health

World Health Organization WHO (2020) C_WHO

This report aims to support countries in the necessary transition toward healthier, more sustainable diets by integrating biodiversity in food-based interventions to support nutrition and health. It is intended to help guide decision-makers in the health, nutrition and other sectors, to: Consider ... the important role of biodiversity in food systems for the development of integrated interventions to support healthy, diverse and sustainable diets; To focus investments and country support for more comprehensive, coordinated and cross-cutting public health and nutrition projects and policies; and To strengthen the resilience of food systems, health systems, and societies, each of which are each increasingly compromised by widespread ecological degradation, biodiversity loss and climate change. Biodiversity at every level (genetic, species and ecosystem level) is a foundational pillar for food security, nutrition, and dietary quality. It is the basic source of variety in essential foods, nutrients, vitamins and minerals, and medicines, and underpins life-sustaining ecosystem services. It is a core environmental determinant of health, often a vital ingredient of healthy nutritional outcomes and livelihoods, gender equality, social equity, and other health determinants. Biodiversity can play a more prominent role in planning for nutritional outcomes in various ways, e.g. by facilitating the production of nutritious fruits and plant products, sustaining livelihoods through more efficient production and increasing the diversity of products available in markets. This Guidance presents and expands on six core building blocks for mainstreaming biodiversity for nutrition and health: Cross-sectoral knowledge development and knowledge co-production; Enabling environments; Integration; Conservation and the wider use of biodiversity; Education and awareness-raising; Monitoring and evaluation; This WHO report builds on an unprecedented opportunity to mainstream biodiversity in order to support healthy and sustainable diets, and offers the necessary technical guidance to catalyze and support a transformation of the global food system and transition to healthier, more sustainable diets. more

Access to medicines: making market forces serve the poor

World Health Organization WHO (2017) C_WHO

Automated Real-time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF System

World Health Organization (2011) C_WHO

Policy Statement

Technique automatisée d’amplification de l’acide nucléique en temps réel pour la détection rapide et simultanée de la tuberculose et de la résistance à la rifampicine : Système Xpert MTB/RIF

Organisation mondiale de la Santé (2011) C_WHO

Innovative Care for Chronic Conditions

Pan American Health Organization PAHO, World Health Organization WHO (2013) CC

Organizing and Delivering High Quality Care for Chronic Noncommunicable Diseases in the Americas

Electronic Tools. Technical Series on Safer Primary Care

World Health Organization WHO (2016) C_WHO

UNAIDS Terminology Guidelines

UNAIDS (2024) CC

Language influences the way we think, how we perceive reality, and how we behave. With respect to HIV, language can embody stigma and discrimination, which impacts access to testing, acquisition of HIV, and engagement with treatment. Language plays a role in supporting respect and empowerment of ind ... more

India: Report of the Core-Committee for Revision of National List of Essential Medicines November 2015

Ministry of Health & Family Welfare (MOHFW), Government of India (2015) C1

Towards Access 2030. WHO Medicines and Health Products Programme Strategic Framework 2016-2030

(2017) C_WHO

WHO Guideline on Country Pharmaceutical Pricing Policies

World Health Organization WHO World Health Organization (2020) C_WHO

In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems’ ability to prov ... more

Kenya Pharmaceutical Sector Development Strategy

United Nations Industrial Develoopment Organization (2012) C1

Global UNIDO Project: Strengthening the local production of essential medicines in least developed and developing countries

Pharmaceutical Sector Profile: Uganda

UN Industrial Development Organization (2010) C1

Global UNIDO Project: Strengthening the local production of essential generic drugs in the least developed and developing countries

India: Pharmaceuticals Annual Report 2016-2017

Government of India, Ministry of Chemicals & Fertilizers, Department of Pharmaceuticals (2017) C1

Uganda: Guidelines on good manufacturing practice for medicinal products - Part 1

National Drug Authority (NDA), Uganda (2017) C2

Poor and Forgotten

BUKO Pharma-Kampagne (2014) C1

Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda

National strategy and plan of action for pharmaceutical manufacturing development in Ethiopia (2015–2025)

Ministry of Health and Ministry of Industry, Federal Democratic Republic of Ethiopia (2015) C1

Strategy plan

Improving Access to and Appropriate Use of Medicines for Mental Disorders
recommended

Corrado Barbui, Tarun Dua, Kavitha Kolappa et al. World Health Organization and Calouste Gulbenkian Foundation (2017) C_WHO